Abstract. N-methyl-N'-nitro-N-nitrosoguanidine (NTG) in high concentrations inactivates extracellular simian virus 40. No mutants were found ;in stocks of virions partially inactivated by NTG under the experimental conditions employed. In contrast, NTG in low concentrations inhibits the intracellular replication of simian virus 40 and is an effective mutagen of the intracellular virus. Six temperature-sensitive mutants of simian virus 40 have been isolated for genetic studies of the virus and its interaction with mammalian cells.
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Simian virus 40 (SV40) is capable of transforming cells in vitro',2 and of inducing neoplasms in animals.3' 4 Several lines of evidence suggest that the DNA of the virus is integrated into the DNA of transformed cells5'6 and can be recovered from them in the infectious form. 7 In most transformed cells only a portion of the genome is expressed. [8] [9] [10] [11] [12] The important question remains whether the portion of the genome thus expressed is responsible for the maintenance of the transformed state. Because of the small size of the SV40 genome, 1314 genetic analysis of all essential viral functions should be possible through the isolation of conditional lethal mutants. Such analysis could provide specific information on the replication of SV40, the integration of genetic material into mammalian cells, the control of genetic expression in cells, and the mechanism of virus-induced neoplastic transformation. ing AH-1 cells with dilute suspensions of virus. When cell destruction was marked, the cultures were frozen and thawed twice, spun at 1200 X g, and stored at -60'C.
N-methyl-N'-nitro-N-nitrosoguanidine (NTG)
Virus assay: AH-1 monolayers were grown in 35-mm Falcon plastic Petri dishes.
The virus inoculum of 0.2 ml per plate was allowed to adsorb for 2 hr at 39CC. The plates were then overlaid with 3 ml of Eagle's basal medium with 1% agar, 0.5% laotalbumen hydrolysate, and 5% fetal calf serum and incubated at the appropriate temperature in an atmosphere of 5% Co2. A second agar overlay of 2 ml containing neutral red
(1: 40,000) was added after a 10-day incubation. Extraction and assay of infectious DNA: Viral DNA was extracted from cells late in the course of infection and assayed on AH-1 cells by the method of Pagano.21
Infected cells were suspended in phosphate-buffered saline free of Ca2+ and Mg2+ and containing 0.5% sodium dodecyl sulfate and 0.008% ethylenediaminetetraacetate, pH 7.2. An equal quantity of cold water-saturated phenol was added, and the mixture was shaken for 10 min at 40C. After centrifugation at 750 X g for 15 min, the aqueous phase was re-extracted twice. The final extraction was dialyzed in phosphate-buffered saline overnight at 40C to remove the phenol. The DNA was plaque-assayed for infectivity in the buffer containing 1 mg/ml DEAE-dextran, mol wt 2 X 106 (Pharmacia, Uppsala, Sweden). The infectious DNA was treated with neutralizing antibody and with DNase to confirm that the extracted DNA and not residual virions accounted for its infectivity. Prior to use for this purpose, 5 ml of rabbit anti-SV40 serum (Microbiological Associates) was precipitated with 5 ml of saturated (NH4)2SO4 and the precipitate was dissolved in 100 ml of the buffer without Ca2+ or Mg2+. The DNA suspension was exposed to an equal volume of anti-SV40 antibody for 30 min at 310 C. Bovine pancreatic DNase purified by electrophoresis was obtained from Worthington Biochemical Corp. Extracted DNA was exposed to 20-200 Kunitz units of DNase in the buffer with Ca2+ and Mg2+ at pH 5.5, 31 C for 30 min.
Preparation of nitrosoguanidine: NTG (Aldrich Chemical Co.) was dissolved in phosphate-buffered saline and sterilized by filtration. Solutions were kept frozen in the dark until used. The final pH of the solutions was 7.0.
Exposure of extracellular virions and DNA to NTG: Pools of virions were filtered through 50-nm membranes (Millipore Corp.) to obtain nonaggregated virus. 22 Virions and extracted DNA suspended in phosphate-buffered saline were each diluted tenfold in solutions of NTG at 310C. Samples of 1 ml were removed at intervals, diluted in 9 ml of cold PBS, and dialyzed at 40C overnight against large quantities of buffer. The samples were stored at -60'C. Prior to examination for the presence of mutants, a portion of the virus stock exposed to NTG for 3 hr was regrown in AH-1 cells (input multiplicity 0.2 plaque-forming units/cell) at 31'C for 5 days so that any potential mutation would be represented in both strands of the viral DNA.
Exposure of replicating virus to NTG: Tube cultures of AH-1 cells were infected with a multiplicity of 5 plaque-forming units/cell. After adsorption for 2 hr at room temperature, the cultures were washed three times, and medium with varying concentrations of freshly thawed NTG was added. The tubes were incubated in the same medium for 5 days at 300C and then harvested as described above. Control cultures were inoculated with either virus or NTG alone and were observed for cytopathic effect.
Examination of treated virus for the presence of temperature-sensitive mutants: Virus exposed to NTG was appropriately diluted in Hanks' salt solution and 0.2 ml were adsorbed to AH-1 cell monolayers in Petri dishes at 31'C for 2 hr. The inoculum was removed and the cells were overlaid with nutrient agar. After 24-days incubation at 310C, well-isolated plaques were picked by gentle aspiration with a capillary pipette. The agar plug was suspended in 2 ml Hanks' solution with 2% fetal calf serum and stored at -600 C. To detect temperature-sensitive mutants, 0.2 ml of each undiluted suspension was added to AH-1 monolayers at 390C. After a 2-hr adsorption period, the cells were overlaid with agar and incubated at 31 sions of most of the clones which were tested for temperature sensitivity contained enough virus to completely lyse the AH-1 monolayers. Those plates in which the monolayers were not completely lysed at 31'C were also evaluated for plaque size.
Results. The effect of temperature of incubation on the replication of SV40: Prior to the search for temperature-sensitive mutants, preliminary experiments were performed to determine the temperature characteristics of SV40-W growth in AH-1 cells. Tube cultures of AH-1 cells were inoculated at a multiplicity of approximately 50 plaque-forming units/cell, washed after a 2-hr adsorption at 250C, and incubated at a wide range of temperatures. Individual cultures were harvested at intervals and the yield of infectious virus was titered after freezing and thawing three times. The effect of incubation temperature on the maximal yields of SV40 is presented in Figure 1 . the virus replicated well at temperatures ranging from 31 to 420C. The attainment of maximal levels of production of new virus was followed shortly by extensive cytopathic effect. At 250C the production of virus was markedly reduced and lysis of cells was not observed. At 440C the number of plaque-forming units released per cell culture was less than the number that remained immediately after adsorption and washing. Extensive degenerative changes were observed in cells of both infected and control cultures maintained at this temperature.
The effect of the temperature of incubation on the time required for the production of initial and maximal yields of SV40 is shown in Figure 2 . The time required to reach maximal production decreased from 120 hr at 31'C to 60 hr at 390C and then increased to 72 hr at 420C.
The efficiency of plaque formation by SV40 in AH-1 cells did not vary appreciably over the temperature range from 31 to 390C. However, the time required for the development of well-defijed plaques was 20 days at 31'C and 10 days at 39"C. Based on this information, 31'C was selected as the permissive temperature and 390C was used as the restrictive temperature in the subsequent attempts to identify temperature-sensitive mutants.
Effects of exposure of extracellular SV4O to NTG: A 1-ml suspension of 108 plaque-forming units of virions in phosphate-buffered saline and a 1-ml suspension containing 105 units extracted Viral DNA in the buffer were added to solutions of 9 ml NTG. Samples were removed, diluted, dialyzed, and titrated for infectivity at hourly intervals. Virus exposed to 100 tig/ml NTG for 3 hr was not measurably inactivated. After exposure to 5000 pg/ml NTG for 3 hr both virions and extracted DNA lost more than 90% of their infectivity (Fig. 3) . Preparations of extracted DNA were shown to be free of residual virions by their susceptibility to DNase, their resistance to neutralizing antibody, and their requirement for DEAE-dextran in plaque titration (Table 1) .
In one experiment the NTG solution was preincubated at 31'C for 24 hr before mixture with the virus suspension to determine the effect of these conditions on the stability of NTG. It was found that the capacity of NTG to inactivate the virus was reduced by more than half in this preincubation.
Exposure of SV40-infected cells to NTG: Monolayers of AH-1 cells which had adsorbed SV40 for 2 hr were continuously exposed to NTG in concentrations ranging from 0.625 to 40 ,g/ml, and the yield of virus from a single growth cycle at 300C was subsequently determined (Fig. 4) . At the high concentrations of NTG, virus yield did not differ significantly from the amount of the residual virus inoculum, and the toxic effect of the drug on uninfected cells was marked. the monolayer. Cultures recovered fully if medium without NTG was added after 5 days. Isolation of mutants: Virus exposed to NTG was plaqued on AH-1 monolayers at 31'C and 1342 well-separated plaques were picked.
The plaque progeny of SV40 treated extracellularly for 3 hr with 5000 ,g NTG/ml were found to contain no temperature-sensitive mutants among 250 clones isolated directly and among 250 clones isolated after regrowth at 310C for 5 days as described in Materials and Methods. The suspensions of 141 of these clones were sufficiently dilute to allow assessment of plaque size on plates inoculated with undiluted suspension. No plaque mutants were found. Among 842 plaque progeny isolated from SV40 replicating in AH-1 cells in the presence of 5 ug/ml NTG, six clones were found to form confluent or nearly confluent plaques after 20 days at 31'C but no plaques after 10-days incubation at 390C. It was possible to assess the size of the plaques induced by 174 of the original 842 clones in the same plating of undiluted suspensions at 310C. Six clones formed uniformly minute plaques and were stable in this characteristic through two plaque passages. None of the minute plaque formers was temperature sensitive (Table 2) .
Plaquing characteristics of temperature-sensitive mutants: All of the temperature-sensitive mutants exhibited a greater efficiency of plaquing at the permissive than at the restrictive temperature by a factor of 104 or more (Table 3) . After periods of incubation longer than 10 days at 39CC, four of the clones formed minute, and often poorly defined, plaques (Table 3) . Monolayer cultures which were inoculated at a multiplicity of more than one temperature-sensitive virus per cell and incubated at 390C showed an irregular pattern of staining with neutral red and no clearly defined plaques were formed.
Discussion. SV40-W has been shown to replicate well and produce complete cytopathic effect in AH-1 cells over a range of 31-42°C. The time required for the initial and maximal yields of new virus decreases approximately twofold with an increase of the temperature from 31 to 390C. The finding of viral replication at 420C is consistent with reports by Jerkofsky and Rapp23 that SV40 replicates to normal yields at 41'C and Kitahara and Melnick24 that SV40 produces T and V antigens in slightly diminished titers at temperatures up to 430C. At 250C we have found that the rate of SV40 replication is significantly slowed and the yield is markedly reduced. These findings are in accord with ability of SV40-infected cells to produce T antigen but very little V antigen at 230C.24 NTG has been shown to inactivate extracellular infectious virions. Aqueous solutions of NTG in concentration approaching saturation decreased the infectivity of monodisperse SV40. The inactivation decreased with time at a variable rate. This finding can be attributed to the instability of NTG in solution since NTG which had been preincubated under experimental conditions for 24 hr caused less inactivation when subsequently added to virus.
The mechanism of inactivation of SV40 by NTG was further investigated by parallel exposure of virions and extracted infectious DNA to NTG. The rates of inactivation of virions and viral DNA by 5000 ,g/ml NTG were similar. These findings suggest that the viral DNA is the target of NTG inactivation and that the protein coat of SV40 provides no significant impediment to the action of NTG.
None of the pools of virions which had been partially inactivated extracellularly by NTG were found to contain temperature-sensitive or plaque mutants. The possibility of mutagenic action of NTG under extracellular conditions other than those employed in these studies has not been eliminated. It is clear, however, that loss of infectivity alone cannot be used as a reliable indication of successful mutagenesis of SV40 by NTG.
Prior studies of the mutagenic effects of NTG on animal viruses have been
